4.900
+8,89%
2026-07-03
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -595.8% | -354.2% | 0 / 3 | -37.0% | -10.99 pp | -6.45 pp | -25.1% | 0.08 | — | 39,5 | −37,0% | −2,3 | −595,8% | — | -6.31 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.900 (close price on 2026-07-03)EPS (TTM): −848,1
Financial charts
1.Revenue & growth
VND bn39,5Q2/26
1.Revenue & growth
VND bn39,5Q2/26
2.Profit & growth
VND bn-2,33Q2/26
3.Profit mix (Penman)
VND bn-17,0Q2/26
4.Margins & cost structure
%8.7%Q2/26
5.Returns & cash cycle
% · days-3.5%Q2/26
6.Earnings quality & cash
VND bn-3,99Q2/26
7.Asset structure
VND bn214Q2/26
8.Funding & debt health
VND bn · times214Q2/26
9.Revenue backlog
VND bn29,9Q2/26
10.Valuation
times · %-5,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-116Q2/26
Adjusted EPS growth, latest quarter
-610%
Average adjusted EPS growth, 3 quarters
-489%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26